These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Influence of intracoronary meglumine diatrizoate on regional myocardial contractility and the protective effect of hydrocortisone. Pasternak RC; Lewis BS; Gotsman MS; Merin G Isr J Med Sci; 1980 Mar; 16(3):185-90. PubMed ID: 7390758 [TBL] [Abstract][Full Text] [Related]
64. Anuria following urography with meglumine diatrizoate (renografin) in multiple myeloma. Gross M; McDonald H; Waterhouse K Radiology; 1968 Apr; 90(4):780-1. PubMed ID: 5640810 [No Abstract] [Full Text] [Related]
65. Identification and description of separate mechanisms for two components of renografin cardiotoxicity. Popio KA; Ross AM; Oravec JM; Ingram JT Circulation; 1978 Sep; 58(3 Pt 1):520-8. PubMed ID: 679443 [No Abstract] [Full Text] [Related]
66. [The serum immunoglobulin indices in side effects to Triombrast administration]. Vaganov NV Urol Nefrol (Mosk); 1997; (2):10-1. PubMed ID: 9206872 [TBL] [Abstract][Full Text] [Related]
67. Vicarious excretion of intravenous diatrizoate (Urograffin) in renal insufficiency: report of two cases. Ogunseyinde AO; Nzeh DA West Afr J Med; 1992; 11(4):304-7. PubMed ID: 1304796 [TBL] [Abstract][Full Text] [Related]
68. Severe thrombocytopenia as a result of contrast left ventricular angiography. Wein P; Handler M; Chadda KD Cathet Cardiovasc Diagn; 1982; 8(5):495-9. PubMed ID: 6890412 [TBL] [Abstract][Full Text] [Related]
69. Clinical evaluation of a new radiographic contrast agent: diatrizoate meglumine 60%. Barrett RB; Owens JM Vet Med Small Anim Clin; 1981 Sep; 76(9):1285-9. PubMed ID: 6916550 [No Abstract] [Full Text] [Related]
70. Anaphylactic death from methylglucamine and sodium diatrizoate (Renovist). Shoultz CA; Dines DE; Peters GA; Witten DM Ann Allergy; 1968 Jan; 26(1):40-3. PubMed ID: 4951626 [No Abstract] [Full Text] [Related]
71. [Urografin, a new drug for excretion urography]. MAY F; SCHILLER M Med Klin; 1954 Aug; 49(35):1403-5. PubMed ID: 13203032 [No Abstract] [Full Text] [Related]
72. [RELIEF RADIOGRAPHY OF A BLADDER TUMOR BY UROGRAFIN]. OKA N; KATO T Rinsho Hoshasen; 1963 Aug; 8():601-6. PubMed ID: 14048590 [No Abstract] [Full Text] [Related]
73. Pretreatment of patients requiring oral contrast abdominal computed tomography with antiemetics: a randomized controlled trial of efficacy. Garra G; Singer AJ; Bamber D; Chohan J; Troxell R; Thode HC Ann Emerg Med; 2009 Apr; 53(4):528-33. PubMed ID: 18640743 [TBL] [Abstract][Full Text] [Related]
74. Liquid chromatographic determination of meglumine diatrizoate in human plasma and urine. Turpeinen U; Pomoell UM J Chromatogr; 1986 Apr; 377():460-5. PubMed ID: 3486875 [No Abstract] [Full Text] [Related]
75. [Study of immunological parameters in radiography and excretory urography]. Vaganov NV Vestn Rentgenol Radiol; 1997; (2):36-8. PubMed ID: 9157666 [TBL] [Abstract][Full Text] [Related]
76. Allergic reaction following micturating cystourethrography. Bettenay F; de Campo J Urol Radiol; 1989; 11(3):167-8. PubMed ID: 2595875 [TBL] [Abstract][Full Text] [Related]
77. Vicarious gastric excretion of intravenous contrast. Meholic AJ; Davis M; Bonmati C Am J Physiol Imaging; 1991; 6(4):197-200. PubMed ID: 1817573 [TBL] [Abstract][Full Text] [Related]
78. [Severe complications from urography]. Keler A; Rerevski M Srp Arh Celok Lek; 1971; 98(9):1193-9. PubMed ID: 5130862 [No Abstract] [Full Text] [Related]
79. The effects of contrast media on renal function in children: comparison of ionic and non-ionic agents. Buyan N; Arab M; Hasanoğlu E; Gökçora N; Ercan S Turk J Pediatr; 1995; 37(4):305-13. PubMed ID: 8560597 [TBL] [Abstract][Full Text] [Related]
80. Serum electrolyte and protein changes after intravenous injection of sodium and meglumine diatrizoate (urograffin-370). Nzeh DA; Erasmus RT; Aiyedun BA Afr J Med Med Sci; 1994 Mar; 23(1):35-7. PubMed ID: 7839944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]